BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10777595)

  • 1. Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes.
    Beier F; Taylor AC; LuValle P
    J Biol Chem; 2000 Apr; 275(17):12948-53. PubMed ID: 10777595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.
    Beier F; Lee RJ; Taylor AC; Pestell RG; LuValle P
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1433-8. PubMed ID: 9990041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating transcription factor 2 targets c-Fos, but not c-Jun, in growth plate chondrocytes.
    Li X; LuValle P
    J Cell Biochem; 2011 Jan; 112(1):211-6. PubMed ID: 21069729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
    James CG; Woods A; Underhill TM; Beier F
    BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes.
    Ma Q; Li X; Vale-Cruz D; Brown ML; Beier F; LuValle P
    J Cell Biochem; 2007 May; 101(2):477-87. PubMed ID: 17219413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.
    Sylvester AM; Chen D; Krasinski K; Andrés V
    J Clin Invest; 1998 Mar; 101(5):940-8. PubMed ID: 9486962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
    Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
    Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
    Shimizu M; Nomura Y; Suzuki H; Ichikawa E; Takeuchi A; Suzuki M; Nakamura T; Nakajima T; Oda K
    Exp Cell Res; 1998 Feb; 239(1):93-103. PubMed ID: 9511728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel DNA regulatory element in the rabbit surfactant protein B (SP-B) promoter that is a target for ATF/CREB and AP-1 transcription factors.
    Berhane K; Boggaram V
    Gene; 2001 May; 268(1-2):141-51. PubMed ID: 11368910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element.
    Sabbah M; Courilleau D; Mester J; Redeuilh G
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11217-22. PubMed ID: 10500157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.
    Lee RJ; Albanese C; Stenger RJ; Watanabe G; Inghirami G; Haines GK; Webster M; Muller WJ; Brugge JS; Davis RJ; Pestell RG
    J Biol Chem; 1999 Mar; 274(11):7341-50. PubMed ID: 10066798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
    Hadzopoulou-Cladaras M; Lavrentiadou SN; Zannis VI; Kardassis D
    Biochemistry; 1998 Oct; 37(40):14078-87. PubMed ID: 9760243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression.
    Beier F; Ali Z; Mok D; Taylor AC; Leask T; Albanese C; Pestell RG; LuValle P
    Mol Biol Cell; 2001 Dec; 12(12):3852-63. PubMed ID: 11739785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cells.
    Ghosh SK; Gadiparthi L; Zeng ZZ; Bhanoori M; Tellez C; Bar-Eli M; Rao GN
    J Biol Chem; 2002 Jun; 277(24):21325-31. PubMed ID: 11925444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
    van Dam H; Castellazzi M
    Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia.
    Beier F; LuValle P
    Mol Endocrinol; 2002 Sep; 16(9):2163-73. PubMed ID: 12198252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2.
    Lewis JS; Vijayanathan V; Thomas TJ; Pestell RG; Albanese C; Gallo MA; Thomas T
    Oncol Res; 2005; 15(3):113-28. PubMed ID: 16050133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the cyclin A promoter by transforming growth factor-beta1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein.
    Yoshizumi M; Wang H; Hsieh CM; Sibinga NE; Perrella MA; Lee ME
    J Biol Chem; 1997 Aug; 272(35):22259-64. PubMed ID: 9268374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.